Journal of Cutaneous and Aesthetic Surgery

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 13  |  Issue : 4  |  Page : 319--325

Bleomycin sclerotherapy in massive macrocystic lymphatic malformation: minimal complications with maximum results


Ankur Bhatnagar, Zafar Neyaz, Brajesh Singh, Ashwani Mishra, Yusuf, Vijai Datta Upadyayaya, Basant Kumar 
 Department of Pediatric Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Correspondence Address:
Vijai Datta Upadyayaya
Department of Pediatric Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, 226014, Uttar Pradesh.
India

Introduction: Cystic lymphangioma (CL) is a multiloculated congenital malformation of the lymphatic system occurring in approximately 1 in 6,000–12,000 births, and it mostly presents at birth. The CL is of a variable size and it can be found at any age and in any part of the body. This study was carried out to observe the effect of intralesional aqueous bleomycin on giant CL presenting in adult and pediatric cases. Materials and Methods: This is an observational study conducted in the department of pediatric surgery and plastic surgery from January 2012 to January 2020. All the diagnosed cases of lymphangioma measuring more than 5 cm in size and managed during this period were reviewed. The cases who had lesions with a vascular component or who had any history of previous surgery or any form of treatment were excluded from the study. A total of 19 cases were included in the study. The primary mode of management of CL at the present center is intralesional bleomycin sclerotherapy (IBS). This is the standard protocol followed at our center to treat the cases with CL. Relevant demographic and clinical data of all the included patients were collected on a structured proforma, and data were analyzed. Result: Four cases had a favorable outcome in a single session, seven cases showed a favorable response after the second session, and three cases showed a favorable response after the third session. Two cases showed a partial response even after the fourth session and were considered nonresponders, one of whom was operated on and the other who was satisfied with a partial response and was not willing to undergo surgical excision. No major complications were observed in the present series. A few cases developed mild pain with or without fever, but none of them required hospitalization. Conclusion: Intralesional bleomycin sclerotherapy (IBS) is a safe, effective, and economical treatment option for the management of large cystic lymphangiomas and it avoids surgery-related complications.Level of Study: IV evidence studyType of Study: Retrospective observational study


How to cite this article:
Bhatnagar A, Neyaz Z, Singh B, Mishra A, Yusuf, Upadyayaya VD, Kumar B. Bleomycin sclerotherapy in massive macrocystic lymphatic malformation: minimal complications with maximum results.J Cutan Aesthet Surg 2020;13:319-325


How to cite this URL:
Bhatnagar A, Neyaz Z, Singh B, Mishra A, Yusuf, Upadyayaya VD, Kumar B. Bleomycin sclerotherapy in massive macrocystic lymphatic malformation: minimal complications with maximum results. J Cutan Aesthet Surg [serial online] 2020 [cited 2022 Jun 30 ];13:319-325
Available from: https://www.jcasonline.com/article.asp?issn=0974-2077;year=2020;volume=13;issue=4;spage=319;epage=325;aulast=Bhatnagar;type=0